Logo image
Sign in
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
Journal article

Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years

M. McClung, A. Balske, D. Burgio, D. Wenderoth and Robert R. Recker
Osteoporosis International, Vol.24(1), pp.301-310
2013
PMID: 23079690

Details